Device Trial Radar · NCT07633535
LVAD Index and Clinical Outcomes in Continuous-Flow LVAD Patients
Last checked: Nov 19, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
34
Actual
Start
Oct 1, 2022
Primary completion
Apr 30, 2023
Study completion Apr 30, 2023
Sponsor
- Lead sponsor
- Gaziantep City HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Antalya City Hospital; Akdeniz University Hospital
- First posted
- Jun 8, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This single-center, observational study evaluated the LVAD index, defined as device-estimated pump flow divided by body surface area, in adult patients supported with continuous-flow left ventricular assist devices. The study included 34 patients with end-stage heart failure who had either an HVAD or HeartMate 3 device and were followed for six months. The study assessed the relationship between LVAD index and selected routine biochemical markers related to hepatic and renal status, including ALT, AST, LDH, BUN, and creatinine. The study also evaluated whether LVAD index was associated with rehospitalization during follow-up.
Conditions
- End-stage Heart Failure
- Left Ventricular Assist Device
- Mechanical Circulatory Support
Interventions
HeartWare Ventricular Assist DeviceDevice
Patients in this group were supported with the HeartWare Ventricular Assist Device as part of routine clinical care. No device assignment or protocol-driven intervention was performed by the study investigators.
HeartMate 3 Left Ventricular Assist DeviceDevice
Patients in this group were supported with the HeartMate 3 left ventricular assist device as part of routine clinical care. No device assignment or protocol-driven intervention was performed by the study investigators.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Association Between LVAD Index and Selected Biochemical MarkersTime frame: Six months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Akdeniz University Faculty of Medicine
Antalya, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.